Skip to main content
Intensive Care Medicine Experimental

Table 6 (abstract A5). Distribution and Outcomes at baseline

From: ESICM LIVES 2016: part one

 

Group I

Group II

Group III

Group IV

p value

OR (95% CI) group IV vs group I

Baseline ARDS diagnosis

SpO2/FiO2 ≥ 190 and PEEP < 10

SpO2/FiO2 ≥ 190 and PEEP ≥ 10

SpO2/FiO2 < 190 and PEEP < 10

SpO2/FiO2 < 190 and PEEP ≥ 10

Number of patients (N)

87

43

100

226

  

ICU mortality (%)

19.5

23.3

18.0

30.1

0.042

1.77 (0.99 - 3.30)

In-hospital mortality (%)

44.8

30.2

36.0

41.2

0.897

0.85 (0.52 - 1.40)

30-day mortality (%)

27.6

27.9

24.0

33.2

0.276

1.30 (0.75 - 2.23)

90 days mortality (%)

47.1

34.9

41.0

42.0

0.636

0.81 (0.50 - 1.34)

1 year mortality (%)

60.9

41.9

47.0

49.6

0.182

0.63 (0.38 - 1.04)

VFD-28 (days-IQR)

19 (7-24)

22 (6.5-25)

20.5 (6-25)

18 (0-23)

0.070*

-

  1. Data are medians [IQR] or percentages
  2. Abbreviations: ARDS acute respiratory distress syndrome, VFD-28 ventilator free days and alive at day 28
  3. P-value is p-for trend or p for Kruskall-Wallis test*
Back to article page